| # | Title | Journal | Year | Citations |
|---|
| 1 | Potential lessons from the Taiwan and New Zealand health responses to the COVID-19 pandemic | The Lancet Regional Health - Western Pacific | 2020 | 187 |
| 2 | Temporal changes in factors associated with COVID-19 vaccine hesitancy and uptake among adults in Hong Kong: Serial cross-sectional surveys | The Lancet Regional Health - Western Pacific | 2022 | 100 |
| 3 | The impact of the COVID-19 pandemic on health services utilization in China: Time-series analyses for 2016–2020 | The Lancet Regional Health - Western Pacific | 2021 | 84 |
| 4 | Long working hours and health | The Lancet Regional Health - Western Pacific | 2021 | 84 |
| 5 | Reasons for being unsure or unwilling regarding intention to take COVID-19 vaccine among Japanese people: A large cross-sectional national survey | The Lancet Regional Health - Western Pacific | 2021 | 84 |
| 6 | Prevalence of stroke in China, 2013–2019: A population-based study | The Lancet Regional Health - Western Pacific | 2022 | 76 |
| 7 | Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study | The Lancet Regional Health - Western Pacific | 2021 | 75 |
| 8 | Clinical characteristics and risk factors for severe COVID-19 infections in Malaysia: A nationwide observational study | The Lancet Regional Health - Western Pacific | 2020 | 71 |
| 9 | An analysis of national action plans on antimicrobial resistance in Southeast Asia using a governance framework approach | The Lancet Regional Health - Western Pacific | 2021 | 64 |
| 10 | Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: A descriptive study | The Lancet Regional Health - Western Pacific | 2022 | 62 |
| 11 | Transmission of Omicron (B.1.1.529) - SARS-CoV-2 Variant of Concern in a designated quarantine hotel for travelers: a challenge of elimination strategy of COVID-19 | The Lancet Regional Health - Western Pacific | 2022 | 60 |
| 12 | Modelling lockdown and exit strategies for COVID-19 in Singapore | The Lancet Regional Health - Western Pacific | 2020 | 57 |
| 13 | The impact of the COVID-19 epidemic on tuberculosis control in China | The Lancet Regional Health - Western Pacific | 2020 | 54 |
| 14 | Building community resilience beyond COVID-19: The Singapore way | The Lancet Regional Health - Western Pacific | 2021 | 50 |
| 15 | Impact of Delta Variant and Vaccination on SARS-CoV-2 Secondary Attack Rate Among Household Close Contacts | The Lancet Regional Health - Western Pacific | 2021 | 49 |
| 16 | Indigenous Australians at increased risk of COVID-19 due to existing health and socioeconomic inequities | The Lancet Regional Health - Western Pacific | 2020 | 47 |
| 17 | Impact of COVID-19 on routine immunisation in South-East Asia and Western Pacific: Disruptions and solutions | The Lancet Regional Health - Western Pacific | 2021 | 47 |
| 18 | Co-benefits of nonpharmaceutical intervention against COVID-19 on infectious diseases in China: A large population-based observational study | The Lancet Regional Health - Western Pacific | 2021 | 46 |
| 19 | Association of Molnupiravir and Nirmatrelvir-Ritonavir with preventable mortality, hospital admissions and related avoidable healthcare system cost among high-risk patients with mild to moderate COVID-19 | The Lancet Regional Health - Western Pacific | 2023 | 46 |
| 20 | A study of breastfeeding practices, SARS-CoV-2 and its antibodies in the breast milk of mothers confirmed with COVID-19 | The Lancet Regional Health - Western Pacific | 2020 | 45 |
| 21 | The impact of the COVID-19 pandemic on cancer diagnosis and service access in New Zealand–a country pursuing COVID-19 elimination | The Lancet Regional Health - Western Pacific | 2021 | 44 |
| 22 | Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study | The Lancet Regional Health - Western Pacific | 2020 | 43 |
| 23 | Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China | The Lancet Regional Health - Western Pacific | 2021 | 41 |
| 24 | Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: A self-controlled case series and nested case-control study | The Lancet Regional Health - Western Pacific | 2022 | 41 |
| 25 | Rapid whole-exome sequencing facilitates precision medicine in paediatric rare disease patients and reduces healthcare costs | The Lancet Regional Health - Western Pacific | 2020 | 40 |
| 26 | COVID-19 Vaccine Hesitancy and Acceptance in a Cohort of Diverse New Zealanders | The Lancet Regional Health - Western Pacific | 2021 | 40 |
| 27 | Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study | The Lancet Regional Health - Western Pacific | 2023 | 40 |
| 28 | Prevalence of tobacco dependence and associated factors in China: Findings from nationwide China Health Literacy Survey during 2018–19 | The Lancet Regional Health - Western Pacific | 2022 | 36 |
| 29 | An assessment of self-reported COVID-19 related symptoms of 227,898 users of a social networking service in Japan: Has the regional risk changed after the declaration of the state of emergency? | The Lancet Regional Health - Western Pacific | 2020 | 34 |
| 30 | Incidence of multiple sclerosis in China: A nationwide hospital-based study | The Lancet Regional Health - Western Pacific | 2020 | 34 |
| 31 | The carbon footprint of hospital diagnostic imaging in Australia | The Lancet Regional Health - Western Pacific | 2022 | 34 |
| 32 | How will mass-vaccination change COVID-19 lockdown requirements in Australia? | The Lancet Regional Health - Western Pacific | 2021 | 32 |
| 33 | Age-specific modifiable risk factor profiles for cardiovascular disease and all-cause mortality: a nationwide, population-based, prospective cohort study | The Lancet Regional Health - Western Pacific | 2021 | 31 |
| 34 | Dietary patterns and cardiometabolic risks in diverse less-developed ethnic minority regions: results from the China Multi-Ethnic Cohort (CMEC) Study | The Lancet Regional Health - Western Pacific | 2021 | 31 |
| 35 | Long-term PM2.5 exposure and depressive symptoms in China: A quasi-experimental study | The Lancet Regional Health - Western Pacific | 2021 | 31 |
| 36 | Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia | The Lancet Regional Health - Western Pacific | 2021 | 30 |
| 37 | Changing epidemiology of hand, foot, and mouth disease in China, 2013−2019: a population-based study | The Lancet Regional Health - Western Pacific | 2022 | 30 |
| 38 | Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: A validation and implementation study | The Lancet Regional Health - Western Pacific | 2021 | 29 |
| 39 | Whole of population-based cohort study of recovery time from COVID-19 in New South Wales Australia | The Lancet Regional Health - Western Pacific | 2021 | 29 |
| 40 | The changing pattern of enteric pathogen infections in China during the COVID-19 pandemic: a nation-wide observational study | The Lancet Regional Health - Western Pacific | 2021 | 29 |
| 41 | Healthcare costs due to low back pain in the emergency department and inpatient setting in Sydney, Australia | The Lancet Regional Health - Western Pacific | 2021 | 28 |
| 42 | Comparison of patient characteristics and in-hospital mortality between patients with COVID-19 in 2020 and those with influenza in 2017–2020: a multicenter, retrospective cohort study in Japan | The Lancet Regional Health - Western Pacific | 2022 | 28 |
| 43 | Projections of heatwave-attributable mortality under climate change and future population scenarios in China | The Lancet Regional Health - Western Pacific | 2022 | 28 |
| 44 | Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study | The Lancet Regional Health - Western Pacific | 2020 | 27 |
| 45 | Large-scale epidemiological monitoring of the COVID-19 epidemic in Tokyo | The Lancet Regional Health - Western Pacific | 2020 | 27 |
| 46 | Trends in management of hip and knee osteoarthritis in general practice in Australia over an 11-year window: a nationwide cross-sectional survey | The Lancet Regional Health - Western Pacific | 2021 | 27 |
| 47 | Patient pathways and delays to diagnosis and treatment of tuberculosis in an urban setting in Indonesia | The Lancet Regional Health - Western Pacific | 2020 | 27 |
| 48 | Settings of virus exposure and their implications in the propagation of transmission networks in a COVID-19 outbreak | The Lancet Regional Health - Western Pacific | 2020 | 26 |
| 49 | Phylogenomic analysis of COVID-19 summer and winter outbreaks in Hong Kong: An observational study | The Lancet Regional Health - Western Pacific | 2021 | 26 |
| 50 | The impact of the COVID-19 pandemic on paediatric health service use within one year after the first pandemic outbreak in New South Wales Australia – a time series analysis | The Lancet Regional Health - Western Pacific | 2022 | 26 |
